C. Ligorio

735 total citations
8 papers, 614 citations indexed

About

C. Ligorio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Ligorio has authored 8 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in C. Ligorio's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). C. Ligorio is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). C. Ligorio collaborates with scholars based in Italy, United States and Switzerland. C. Ligorio's co-authors include Federico Cappuzzo, Elisa Rossi, Lucio Crinò, Stefania Bartolini, Alessandra Cancellieri, Elisabetta Magrini, Luca Toschi, Giovanni Luca Ceresoli, Giovanna Finocchiaro and Vanesa Gregorc and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

C. Ligorio

8 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Ligorio Italy	6	426	404	230	108	87	8	614
Rebekah A. Burich United States	13	367 0.9×	452 1.1×	262 1.1×	264 2.4×	108 1.2×	22	710
Shinji Nakamichi Japan	13	281 0.7×	268 0.7×	238 1.0×	88 0.8×	82 0.9×	51	566
Teresa M. Hopper United States	4	204 0.5×	231 0.6×	243 1.1×	101 0.9×	46 0.5×	6	486
F. Cardenal Spain	8	585 1.4×	632 1.6×	416 1.8×	202 1.9×	96 1.1×	26	946
Johann Raats South Africa	9	367 0.9×	280 0.7×	188 0.8×	83 0.8×	101 1.2×	15	569
Anne-Marie Martin United States	4	403 0.9×	215 0.5×	396 1.7×	206 1.9×	66 0.8×	5	713
Seisuke Nagase Japan	11	607 1.4×	681 1.7×	174 0.8×	104 1.0×	40 0.5×	18	841
Antonella Flacco Italy	9	381 0.9×	482 1.2×	269 1.2×	179 1.7×	67 0.8×	13	623
Assunta Sgambato Italy	15	441 1.0×	416 1.0×	293 1.3×	125 1.2×	53 0.6×	31	742
Minhao Fan China	6	305 0.7×	268 0.7×	175 0.8×	134 1.2×	55 0.6×	11	531

Countries citing papers authored by C. Ligorio

Since Specialization

Citations

This map shows the geographic impact of C. Ligorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ligorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ligorio more than expected).

Fields of papers citing papers by C. Ligorio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ligorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ligorio. The network helps show where C. Ligorio may publish in the future.

Co-authorship network of co-authors of C. Ligorio

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ligorio. A scholar is included among the top collaborators of C. Ligorio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ligorio. C. Ligorio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Cappuzzo, Federico, Giovanni Tallini, Giovanna Finocchiaro, et al.. (2009). Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients. Annals of Oncology. 21(3). 562–567. 67 indexed citations

2.

Cappuzzo, Federico, Marileila Varella‐Garcia, Giovanna Finocchiaro, et al.. (2008). Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients. British Journal of Cancer. 99(1). 83–89. 145 indexed citations

3.

Finocchiaro, Giovanna, Federico Cappuzzo, Emanuela Rossi, et al.. (2008). Insuline like growth factor receptor-1 (IGFR-1), MET, and BRAF and primary resistance to cetuximab therapy in colorectal cancer patients. Journal of Clinical Oncology. 26(15_suppl). 4135–4135. 7 indexed citations

4.

Cappuzzo, Federico, C. Ligorio, Luca Toschi, et al.. (2007). EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 2(5). 423–429. 71 indexed citations

5.

Toschi, Luca, Giulio Metro, Elisabetta Magrini, et al.. (2006). EGFR, HER2, and phospho-Akt are not predictive factors for response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7111–7111. 3 indexed citations

6.

Cappuzzo, Federico, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.. (2004). Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 96(15). 1133–1141. 311 indexed citations

7.

Cappuzzo, Federico, Elisabetta Magrini, Stefania Bartolini, et al.. (2004). Improved efficacy of gefitinib therapy in phospho-Akt positive patients with advanced non-small cell lung cancer. Journal of Clinical Oncology. 22(14_suppl). 3004–3004. 9 indexed citations

8.

Cappuzzo, Federico, Elisabetta Magrini, Stefania Bartolini, et al.. (2004). Improved efficacy of gefitinib therapy in phospho-Akt positive patients with advanced non-small cell lung cancer. Journal of Clinical Oncology. 22(14_suppl). 3004–3004. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact